sAng-2 was elevated in patients with hepatocellular carcinoma, suggesting the potential use of angiopoietin-2 as a valuable diagnostic biomarker for the detection of hepatocellular carcinoma (Bouattour, Payance & Wassermann, 2015). This evidence concerns the gene ANGPT2 and hepatocellular carcinoma.